128 related articles for article (PubMed ID: 18351133)
1. Association of CYP1A1 polymorphisms with breast cancer in North Indian women.
Singh N; Mitra AK; Garg VK; Agarwal A; Sharma M; Chaturvedi R; Rath SK
Oncol Res; 2007; 16(12):587-97. PubMed ID: 18351133
[TBL] [Abstract][Full Text] [Related]
2. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.
Kiruthiga PV; Kannan MR; Saraswathi C; Pandian SK; Devi KP
Asian Pac J Cancer Prev; 2011; 12(8):2133-8. PubMed ID: 22292665
[TBL] [Abstract][Full Text] [Related]
4. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
Inoue K; Asao T; Shimada T
Xenobiotica; 2000 Mar; 30(3):285-95. PubMed ID: 10752643
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the Risk of Oral Pre-Cancer and Cancer in North India Population by CYP1A1 Polymorphism Genotypes and Haplotype.
Nigam K; Sanyal S; Gupta S; Gupta OP; Mahdi AA; Bhatt MLB
Asian Pac J Cancer Prev; 2019 Feb; 20(2):345-354. PubMed ID: 30803192
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP1A1 A4889G and T6235C polymorphisms with the risk of sporadic breast cancer in Brazilian women.
Oliveira CB; Cardoso-Filho C; Bossi LS; Lourenço GJ; Costa-Gurgel MS; Lima CS
Clinics (Sao Paulo); 2015 Oct; 70(10):680-5. PubMed ID: 26598080
[TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphisms of the Human Cytochrome P450 1A1 (CYP1A1) and Cervical Cancer Susceptibility among Northeast Thai Women.
Wongpratate M; Ishida W; Phuthong S; Natphopsuk S; Ishida T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):243-248. PubMed ID: 31983191
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
9. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism analysis of the CYP1A1 locus in Koreans: presence of the solitary m2 allele.
Kim KS; Ryu SW; Kim YJ; Kim E
Mol Cells; 1999 Feb; 9(1):78-83. PubMed ID: 10102576
[TBL] [Abstract][Full Text] [Related]
11. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Jul; 122(2):459-69. PubMed ID: 20035380
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian population.
Abbas M; Srivastava K; Imran M; Banerjee M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():68-74. PubMed ID: 24657182
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
14. Lack of Association between CYP1A1 M2 and M4 Polymorphisms and Breast Carcinoma in Jordanian Women: a Case-Control Study.
Amrani I; Bulatova N; Awidi A; Yousef AM; Melhem JM; Al-Masri M; Tahoun LA
Asian Pac J Cancer Prev; 2016; 17(1):387-93. PubMed ID: 26838244
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1, GSTM1 and GSTT1 genetic polymorphism is associated with susceptibility to polycystic ovaries in South Indian women.
Babu KA; Rao KL; Kanakavalli MK; Suryanarayana VV; Deenadayal M; Singh L
Reprod Biomed Online; 2004 Aug; 9(2):194-200. PubMed ID: 15333250
[TBL] [Abstract][Full Text] [Related]
17. Frequency Evaluation of T6235C (m1) and A4889G (m2) Polymorphisms of CYP1A1 Gene in a Healthy Population from the west of Mazandaran Province, Iran.
Ahangar N; Alizadeh B; Tousi A
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):90-6. PubMed ID: 27453279
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clamping.
Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
Pharmacogenetics; 1997 Aug; 7(4):303-7. PubMed ID: 9295058
[TBL] [Abstract][Full Text] [Related]
19. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
Shen Y; Li DK; Wu J; Zhang Z; Gao E
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
[TBL] [Abstract][Full Text] [Related]
20. Clinical effects of A4889G and T6235C polymorphisms in cytochrome P-450 CYP1A1 for breast cancer patients treated with tamoxifen: implications for tumor aggressiveness and patient survival.
Cardoso-Filho C; Sarian LO; de Oliveira CB; da Silveira Bossi L; Lourenço GJ; Lima CS; Gurgel MS
Cancer Chemother Pharmacol; 2013 Sep; 72(3):529-35. PubMed ID: 23842721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
